Modulating immune responses and inflammation

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Standard

Modulating immune responses and inflammation. / Leder, Christoph; Ziegler, M.; Gawaz, Meinrad.

in: Seminars in Thrombosis and Hemostasis, Jahrgang 36, Nr. 2, 03.2010, S. 219-222.

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Harvard

APA

Vancouver

Leder C, Ziegler M, Gawaz M. Modulating immune responses and inflammation. Seminars in Thrombosis and Hemostasis. 2010 Mär;36(2):219-222. doi: 10.1055/s-0030-1251507

Bibtex

@article{a1d733a229b44b78b980bf5fcd213685,
title = "Modulating immune responses and inflammation",
abstract = "New disease-modifying therapeutic options for immune diseases in general and immune-related cardiovascular diseases are urgently needed. Various innovative therapies are currently developed ranging from small molecules and natural compounds to biopharmaceuticals. This article summarizes the overview of possible points of intervention for an ongoing immune response and lists examples of currently developed therapeutic exploitations of these targets. Research and development for the treatment of autoimmune and inflammatory diseases in general will most likely be fruitful also for therapy of immune-related cardiovascular diseases such as myocarditis and atherosclerosis and should be closely followed by research groups focused on cardiovascular immunology.",
keywords = "Chemistry, Modellierung, Immunantwort, Inflammation , immune response, immune modulation, myocarditis",
author = "Christoph Leder and M. Ziegler and Meinrad Gawaz",
year = "2010",
month = mar,
doi = "10.1055/s-0030-1251507",
language = "English",
volume = "36",
pages = "219--222",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme",
number = "2",

}

RIS

TY - JOUR

T1 - Modulating immune responses and inflammation

AU - Leder, Christoph

AU - Ziegler, M.

AU - Gawaz, Meinrad

PY - 2010/3

Y1 - 2010/3

N2 - New disease-modifying therapeutic options for immune diseases in general and immune-related cardiovascular diseases are urgently needed. Various innovative therapies are currently developed ranging from small molecules and natural compounds to biopharmaceuticals. This article summarizes the overview of possible points of intervention for an ongoing immune response and lists examples of currently developed therapeutic exploitations of these targets. Research and development for the treatment of autoimmune and inflammatory diseases in general will most likely be fruitful also for therapy of immune-related cardiovascular diseases such as myocarditis and atherosclerosis and should be closely followed by research groups focused on cardiovascular immunology.

AB - New disease-modifying therapeutic options for immune diseases in general and immune-related cardiovascular diseases are urgently needed. Various innovative therapies are currently developed ranging from small molecules and natural compounds to biopharmaceuticals. This article summarizes the overview of possible points of intervention for an ongoing immune response and lists examples of currently developed therapeutic exploitations of these targets. Research and development for the treatment of autoimmune and inflammatory diseases in general will most likely be fruitful also for therapy of immune-related cardiovascular diseases such as myocarditis and atherosclerosis and should be closely followed by research groups focused on cardiovascular immunology.

KW - Chemistry

KW - Modellierung

KW - Immunantwort

KW - Inflammation

KW - immune response

KW - immune modulation

KW - myocarditis

U2 - 10.1055/s-0030-1251507

DO - 10.1055/s-0030-1251507

M3 - Journal articles

C2 - 20414838

VL - 36

SP - 219

EP - 222

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 2

ER -

DOI